Health Recovery Solutions

Provides remote patient monitoring solutions

Hoboken, New Jersey, United States

About Health Recovery Solutions

Health Recovery Solutions (HRS) provides remote patient monitoring solutions to healthcare organizations, helping them manage patient care from a distance. Their main product, PatientConnect®, is a customizable kit that allows patients to monitor their own health, enabling healthcare providers to keep track of many patients simultaneously. HRS stands out from competitors by offering EHR integration, which helps streamline workflows and enrich patient records with real-time data. Additionally, they provide reimbursement support, assisting healthcare providers in navigating the claims process. The goal of HRS is to improve patient outcomes and reduce healthcare costs through effective remote care solutions.

Hoboken, New JerseyHeadquarters
2012Year Founded
$81.8MTotal Funding
SERIES_CCompany Stage
Enterprise Software, HealthcareIndustries
51-200Employees

Benefits

Flexible PTO
Company-sponsored events
Medical, dental, and vision plans (100% covered options)
3 months paid parental leave

Risks

Increased competition from emerging RPM companies threatens HRS's market share.
Rapid technological advancements require continuous R&D investment, straining financial resources.
Changes in reimbursement policies could impact HRS's revenue streams.

Differentiation

HRS offers a comprehensive suite of remote care solutions for diverse healthcare needs.
PatientConnect® platform empowers patients to manage their health with customizable monitoring kits.
HRS provides EHR integration, optimizing workflows and enriching electronic health records.

Upsides

HRS's strategic partnerships expand its reach and enhance service offerings.
The growing demand for RPM aligns with HRS's focus on chronic conditions like CHF and Diabetes.
Jason Comer's leadership positions HRS for growth and innovation in digital health.

Funding

Total raised$81.81 M
Latest valuation$350.00 M
StageSERIES_C
$70
$350.00 M
EARLY VC
8/31/2019
$10
$50.00 M
DEBT
9/30/2018
$3
SERIES A
12/31/2014
$1
$5.00 M
SEED
1/31/2014
N/A
$1.00 M